Mitchell, Duane A.
Batich, Kristen A.
Gunn, Michael D.
Huang, Min-Nung
Sanchez-Perez, Luis
Nair, Smita K.
Congdon, Kendra L.
Reap, Elizabeth A.
Archer, Gary E.
Desjardins, Annick
Friedman, Allan H.
Friedman, Henry S.
Herndon II, James E.
Coan, April
McLendon, Roger E.
Reardon, David A.
Vredenburgh, James J.
Bigner, Darell D.
Sampson, John H.
Article History
Received: 6 December 2013
Accepted: 13 February 2015
First Online: 11 March 2015
Competing interests
: D.A.M., K.A.B. and J.H.S. have filed provisional patents related to the use of Td pre-conditioning as a method to improve immunization efficacy. D.A.M. has served as a paid member of the Schering Plough North American Investigators Advisory Board. S.K.N. is a co-inventor on a patent that describes the use of DCs transfected with tumour antigen encoding RNA that has been licensed by Argos Therapeutics through Duke University. S.K.N. has no financial interests in Argos Therapeutics and is not compensated by Argos Therapeutics. D.A.R. has served as paid speaker for Schering/Merck and Genentech/Roche. The remaining authors declare no competing financial interests.